In the specification sheet for the Illumina IIx upgrade, I see data output for 2x50 experiment as 9.5-12 GB. They specify that they are "high quality" reads because they pass v1.3 filters. Does anyone know what percentage of high quality reads are generally mappable to the reference genome?
-
-
That is highly dependent on the quality of your library, the organism you're sequencing and the alignment algorithm you're using. As well as your definition of 'mapping' back to the genome.
For example with PhiX, you generally get greater than 98% of your reads mapping back to the genome using ELAND since you don't have to worry about reads in repeat regions or contamination. With human you'll get around 80% mapping back to the genome (depending on your library prep) using ELAND. The reason that the results for human are worse than PhiX is that ELAND only maps back unique alignments and the human genome sequence is highly repetitive (ie. any unknown region isn't going to align, and if you have the same sequence twice it won't count it unless it can resolve it's pair). ELAND also can't handle more than 2 errors in the seed it uses for the alignment so you lose some that way.
Hope this helps,
BradLast edited by basickler; 04-10-2009, 08:55 AM.
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment